Prostaglandin Analogs May Aggravate Myopic Regression after Laser In Situ Keratomileusis

American Journal of Ophthalmology

Volumn 147, Issue 4, 2009, Pages 754-

  Nowroozzadeh, Mohammad H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN F2 ALPHA;

CORNEA STROMA; CORNEA THICKNESS; HUMAN; KERATOMILEUSIS; LETTER; MEDICAL RESEARCH; MYOPIA; PRIORITY JOURNAL;

ADMINISTRATION, TOPICAL; ANTIHYPERTENSIVE AGENTS; CORNEA; HUMANS; INTRAOCULAR PRESSURE; KERATOMILEUSIS, LASER IN SITU; LASERS, EXCIMER; MYOPIA; OPHTHALMIC SOLUTIONS; POSTOPERATIVE COMPLICATIONS; PROPANOLAMINES; PROSTAGLANDINS F, SYNTHETIC; REFRACTION, OCULAR; VISUAL ACUITY;

EID: 62649171788     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.12.013     Document Type: Letter

References (5)

1. Kamiya K., Aizawa D., Igarashi A., et al. Effects of antiglaucoma drugs on refractive outcomes in eyes with myopic regression after laser in situ keratomileusis. Am J Ophthalmol 145 (2008) 233-238
2. Stefan C., Dumitrica D.M., Tebeanu E., et al. Prostaglandin analogues and central corneal thickness. Oftalmologia 51 (2007) 95-99
3. Viestenz A., Martus P., Schlötzer-Schrehardt U., et al. Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness-a cross-sectional study on 403 eyes. Klin Monatsbl Augenheilkd 221 (2004) 753-756
4. Wu K.Y., Wang H.Z., and Hong S.J. Effect of latanoprost on cultured porcine corneal stromal cells. Curr Eye Res 30 (2005) 871-879
5. Amano S., Nakai Y., Ko A., et al. A case of keratoconus progression associated with the use of topical latanoprost. Jpn J Ophthalmol 52 (2008) 334-336